首页 工具
登录
购物车

搜索结果

Search Results for " jbj-04-125-02 "

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name Target Signaling Pathways
T11714 JBJ-04-125-02

JAK Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells
JBJ-04-125-02 can inhibit cancer cell proliferation and EGFRL858R/T790M/C797S signaling. JBJ-04-125-02 has anti-tumor activities. JBJ-04-125-02 is a potent, mutant-selective, allosteric and orally active EGFR inhibitor with an IC50 of 0.26 nM for EGFRL858
T8872 (Rac)-JBJ-04-125-02

JBJ-04-125-02

EGFR Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors
(Rac)-JBJ-04-125-02 (JBJ-04-125-02) 是 JBJ-04-125-02 的消旋体,是选择性突变,可口服的 EGFR 变构抑制剂,对EGFRL858R/T790M 的IC50为 0.26 nM。

化合物

JBJ-04-125-02
Cat.No: T11714
Synonym:
Target: JAK
(Rac)-JBJ-04-125-02
Cat.No: T8872
Synonym: JBJ-04-125-02
Target: EGFR
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼